GlycoMimetics Total Assets from 2010 to 2024

GLYC Stock  USD 0.32  0.03  10.34%   
GlycoMimetics' Total Assets are increasing over the years with slightly volatile fluctuation. Overall, Total Assets are expected to go to about 88.5 M this year. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2011-12-31
Previous Quarter
24.4 M
Current Value
15.7 B
Quarterly Volatility
2.3 B
 
Yuan Drop
 
Covid
Check GlycoMimetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GlycoMimetics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 217.6 K, Interest Expense of 56.3 M or Total Revenue of 9.5 K, as well as many indicators such as Price To Sales Ratio of 15.7 K, Dividend Yield of 0.0 or PTB Ratio of 1.98. GlycoMimetics financial statements analysis is a perfect complement when working with GlycoMimetics Valuation or Volatility modules.
  
Check out the analysis of GlycoMimetics Correlation against competitors.
For information on how to trade GlycoMimetics Stock refer to our How to Trade GlycoMimetics Stock guide.

Latest GlycoMimetics' Total Assets Growth Pattern

Below is the plot of the Total Assets of GlycoMimetics over the last few years. Total assets refers to the total amount of GlycoMimetics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in GlycoMimetics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. GlycoMimetics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GlycoMimetics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 45.32 M10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

GlycoMimetics Total Assets Regression Statistics

Arithmetic Mean77,591,894
Geometric Mean54,909,619
Coefficient Of Variation78.50
Mean Deviation49,541,803
Median51,811,000
Standard Deviation60,909,355
Sample Variance3709.9T
Range209.6M
R-Value0.45
Mean Square Error3194.6T
R-Squared0.20
Significance0.09
Slope6,097,370
Total Sum of Squares51939.3T

GlycoMimetics Total Assets History

202488.5 M
202345.3 M
202251.8 M
202194.3 M
2020142.8 M
2019168 M
2018214.8 M

Other Fundumenentals of GlycoMimetics

GlycoMimetics Total Assets component correlations

0.98-0.32-0.98-0.330.790.161.00.560.370.940.540.610.60.490.47-0.050.12
0.98-0.36-1.0-0.260.790.070.980.560.380.960.540.60.590.560.55-0.110.19
-0.32-0.360.280.42-0.450.79-0.32-0.57-0.51-0.2-0.29-0.41-0.520.120.13-0.28-0.06
-0.98-1.00.280.23-0.78-0.15-0.98-0.53-0.35-0.96-0.53-0.58-0.56-0.58-0.560.13-0.19
-0.33-0.260.420.23-0.30.01-0.32-0.89-0.66-0.12-0.25-0.88-0.70.620.63-0.89-0.17
0.790.79-0.45-0.78-0.3-0.090.790.50.60.740.440.50.670.320.31-0.010.25
0.160.070.79-0.150.01-0.090.15-0.11-0.170.15-0.20.05-0.10.110.11-0.090.17
1.00.98-0.32-0.98-0.320.790.150.550.370.940.550.60.590.490.48-0.050.11
0.560.56-0.57-0.53-0.890.5-0.110.550.750.390.390.950.85-0.32-0.330.710.3
0.370.38-0.51-0.35-0.660.6-0.170.370.750.220.310.670.77-0.29-0.30.50.45
0.940.96-0.2-0.96-0.120.740.150.940.390.220.490.50.420.670.66-0.210.13
0.540.54-0.29-0.53-0.250.44-0.20.550.390.310.490.380.590.270.270.08-0.29
0.610.6-0.41-0.58-0.880.50.050.60.950.670.50.380.78-0.24-0.250.680.32
0.60.59-0.52-0.56-0.70.67-0.10.590.850.770.420.590.78-0.16-0.170.470.18
0.490.560.12-0.580.620.320.110.49-0.32-0.290.670.27-0.24-0.161.0-0.810.02
0.470.550.13-0.560.630.310.110.48-0.33-0.30.660.27-0.25-0.171.0-0.810.01
-0.05-0.11-0.280.13-0.89-0.01-0.09-0.050.710.5-0.210.080.680.47-0.81-0.81-0.01
0.120.19-0.06-0.19-0.170.250.170.110.30.450.13-0.290.320.180.020.01-0.01
Click cells to compare fundamentals

About GlycoMimetics Financial Statements

GlycoMimetics stakeholders use historical fundamental indicators, such as GlycoMimetics' Total Assets, to determine how well the company is positioned to perform in the future. Although GlycoMimetics investors may analyze each financial statement separately, they are all interrelated. For example, changes in GlycoMimetics' assets and liabilities are reflected in the revenues and expenses on GlycoMimetics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in GlycoMimetics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Assets45.3 M88.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether GlycoMimetics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GlycoMimetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Glycomimetics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Glycomimetics Stock:
Check out the analysis of GlycoMimetics Correlation against competitors.
For information on how to trade GlycoMimetics Stock refer to our How to Trade GlycoMimetics Stock guide.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlycoMimetics. If investors know GlycoMimetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlycoMimetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.62)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.59)
Return On Equity
(1.04)
The market value of GlycoMimetics is measured differently than its book value, which is the value of GlycoMimetics that is recorded on the company's balance sheet. Investors also form their own opinion of GlycoMimetics' value that differs from its market value or its book value, called intrinsic value, which is GlycoMimetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlycoMimetics' market value can be influenced by many factors that don't directly affect GlycoMimetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlycoMimetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if GlycoMimetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlycoMimetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.